Baldwin Brothers Inc. MA lessened its holdings in Colgate-Palmolive (NYSE:CL) by 20.9% in the first quarter, HoldingsChannel.com reports. The firm owned 6,665 shares of the company’s stock after selling 1,760 shares during the period. Baldwin Brothers Inc. MA’s holdings in Colgate-Palmolive were worth $457,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also made changes to their positions in CL. Capital Financial Planning LLC bought a new position in Colgate-Palmolive in the 4th quarter valued at $27,000. Timber Creek Capital Management LLC grew its stake in shares of Colgate-Palmolive by 247.1% during the 4th quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock worth $28,000 after acquiring an additional 336 shares during the period. Parisi Gray Wealth Management grew its stake in shares of Colgate-Palmolive by 365.3% during the 4th quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock worth $28,000 after acquiring an additional 369 shares during the period. Portfolio Solutions LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter worth $30,000. Finally, WP Advisors LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter worth $34,000. Hedge funds and other institutional investors own 76.27% of the company’s stock.
CL has been the subject of several research reports. Goldman Sachs Group upgraded Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research note on Tuesday, January 8th. BNP Paribas upgraded Colgate-Palmolive from an “underperform” rating to a “neutral” rating and increased their price target for the stock from $56.00 to $67.00 in a research note on Monday, February 11th. Jefferies Financial Group reiterated a “hold” rating and set a $61.00 price target on shares of Colgate-Palmolive in a research note on Friday, February 1st. Evercore ISI initiated coverage on Colgate-Palmolive in a research note on Thursday, January 10th. They set an “outperform” rating and a $70.00 price target for the company. Finally, Morgan Stanley set a $62.00 price target on Colgate-Palmolive and gave the stock a “hold” rating in a research note on Tuesday, January 29th. Three investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company’s stock. Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $65.73.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 25th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.01. The business had revenue of $3.81 billion for the quarter, compared to analysts’ expectations of $3.78 billion. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The firm’s quarterly revenue was down 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.75 EPS. As a group, research analysts expect that Colgate-Palmolive will post 2.83 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a dividend of $0.43 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. The ex-dividend date of this dividend is Wednesday, April 17th. This represents a $1.72 dividend on an annualized basis and a yield of 2.50%. Colgate-Palmolive’s dividend payout ratio is 57.91%.
In related news, insider Ian M. Cook sold 17,750 shares of the stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $68.61, for a total transaction of $1,217,827.50. Following the sale, the insider now owns 1,111,293 shares of the company’s stock, valued at approximately $76,245,812.73. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Henning I. Jakobsen sold 969 shares of the stock in a transaction dated Tuesday, February 19th. The stock was sold at an average price of $66.39, for a total value of $64,331.91. Following the sale, the chief financial officer now directly owns 35,208 shares in the company, valued at approximately $2,337,459.12. The disclosure for this sale can be found here. Insiders have sold a total of 103,200 shares of company stock worth $6,900,449 in the last three months. 1.14% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Baldwin Brothers Inc. MA Sells 1,760 Shares of Colgate-Palmolive (CL)” was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/04/25/baldwin-brothers-inc-ma-sells-1760-shares-of-colgate-palmolive-cl.html.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Read More: Hedge Funds – Risk or Reward?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.